The efficiency of this single molecule combining the pharmacologic effects of GIP and GLP-1 is mainly due to the insulinotropic action of both compounds through different mechanisms [116,126], displaying higher effects on the reduction of body weight and on the improvement of both insulin resistance and glucose intolerance than when administrated separately [126]. This evidence concerns the gene GLP1R and Glucose intolerance.